Enjoy complimentary customisation on priority with our Enterprise License!
The cartilage repair market size is estimated to grow by USD 1.24 billion, at a CAGR of 16.79% between 2023 and 2028. The market's growth is driven by several factors, including the increasing incidence of osteoarthritis, the rising number of sports injuries, and the growing obese population. The prevalence of osteoarthritis leads to a higher demand for treatment options and supportive products. Similarly, an increase in sports-related injuries boosts the need for effective rehabilitation and medical interventions. Additionally, the rising rates of obesity contribute to various health complications, further driving the need for medical treatments and healthcare services. These factors collectively propel the market's expansion. Our market growth and forecasting report examines historical data from 2018-2022, besides analyzing the current market scenario.
A considerable obese population change has been observed in the lifestyle and diet habits of individuals over the past two decades. Consumerism and urbanization are the major reasons for this shift, which is leading to a high intake of artificial food products. Thus, the sedentary lifestyle and the lack of a balanced diet resulted in an increased incidence of obesity. Being overweight increases, the load exerted on joints, such as the knee, which causes tension and may speed up the breakdown of cartilage. Further, the inflammation of adipose tissue and dyslipidemia associated with obesity also contribute to obesity-induced osteoarthritis. Thus, the growing obese population will lead to an increased incidence of cartilage damage, which in turn will spur the growth of the market in focus during the forecast period.
To learn more about this report, Download Report Sample
The market share by the cell-based segment will be significant during the forecast period. Cell-based techniques, alone or in combination with scaffolds/biological signals, open up many new opportunities for cartilage tissue engineering. Cartilage cell therapy is a treatment that involves the usage of the patient's own cells (autologous) as a therapeutic tool to treat cartilage injury and osteochondral abnormalities. Bone cartilage cell therapy is a long-term treatment for cartilage damage and knee pain that regenerates and restores mobility. The main cell types used in treating chondral or osteochondral abnormalities in joints are chondrocytes and mesenchymal stromal cells obtained from bone marrow, adipose tissue, or the umbilical cord.
Get a glance at the market contribution of various segments Download PDF Sample
The cell-based segment was valued at USD 339.21 million in 2018. One of the biggest potential benefits of employing MSCs (or chondrocytes) is that these cells may be cultured on a vast scale without changing their morphologies. For the treatment of focal, traumatic chondral lesions of the knee, cell-based regenerative therapies have become standard practice. Matrix-assisted autologous chondrocyte transplantation (MACT), in particular, demonstrates promising long-term results in terms of radiological, histological, and clinical outcomes for the treatment of extensive cartilage lesions. Thus, the growing popularity of cell-based therapy owing to its long-term results and effectiveness will boost the growth of the cell-based segment of the market during the forecast period.
Hospitals and clinics emerged as the primary and fastest-growing users of the market in 2023, attributed to rising obesity rates and an aging population worldwide, a significant factor in cartilage damage. Demand for repair therapies is anticipated to rise with increasing orthopedic disorders. With over 22,965 orthopedic surgeons in the US and approximately 790,000 knee replacements annually, hospitals are pivotal. Partnerships with surgery centers are sought, given joint replacements' substantial revenue. Notably, hospitals like Abbott NorthWestern Hospital perform thousands of orthopedic procedures yearly, reflecting quality care and patient satisfaction, driving the market growth. Expansion of healthcare infrastructure and hospital numbers, particularly in emerging economies like India and Malaysia, is further propelling the demand, indicating sustained growth.
Ambulatory Surgery Centers (ASCs) offer scheduled surgeries without overnight hospitalization. They operate in physician offices or independent facilities. ASCs may be within or separate from hospitals, sometimes owned by anesthesiologists or surgeons. These outpatient centers, also called outpatient surgery centers, perform short-term surgeries like joint and tendon repairs. Procedures like knee cartilage restoration and meniscus repair are common, cost-effective outpatient treatments. ASC's popularity is rising due to cost-effectiveness and convenience, with over 8,000 in the US by 2023. As healthcare cost reduction becomes crucial, ASCs' global market is projected to grow.
For more insights about the market share of various regions Download PDF Sample now!
North America is estimated to contribute 39% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers will shape the market during the forecast period. The US and Canada are the major revenue contributors in the market in North America. The market in the region is driven by improved healthcare infrastructure, an increasing number of orthopedic surgeries, and the growing prevalence of obesity and its related risk factors. Factors such as the rising prevalence of OA, favorable reimbursement for cartilage repair surgery, and initiatives by governments and non-profit organizations to create awareness about cartilage damage and its consequences are driving market growth in the region.
In addition, the increasing number of cartilage repair surgeries aided by the growing number of hospitals and ASCs are contributing to the growth of the market in North America. Also, the growing number of ASCs has led to a rise in the number of cartilage repair surgeries performed in the developed countries of the region, such as the US. Thus, the growing number of hospitals in these developed countries, such as the US and Canada, adds to the number of surgical procedures performed, which, in turn, will boost the market in the region during the forecast period.
Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 22 market companies, including:
3M Co.: The company offers cartilage repair solutions through its subsidiary Acelity, such as the FISTULA solutions device.
Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.
The market is expanding rapidly, driven by advances in medical technology and increasing awareness of orthopedic health. This market addresses the significant need for solutions to treat cartilage damage caused by natural disasters such as hurricanes, floods, wildfires, and earthquakes. Utilizing computer-aided design and building information modeling, the market supports the development of innovative treatments and therapies. Key areas of application include residential homes, commercial buildings, educational facilities, and even airports. The shift towards off-site building and modular construction in medical facilities ensures quality control, reduces material waste, and lowers energy consumption. Permanent construction and permanent modular construction techniques offer durability and efficiency, cutting down on project completion times. Compliance with state level regulations and guidelines set by administrative agencies ensures that all practices meet high standards of care and effectiveness. Our researchers analyzed the data with 2023 as the base year and the key drivers, trends, and challenges.
The increasing incidence of Osteoarthritis is the key factor driving the market. Osteochondritis, characterized by cartilage damage triggering chondrocyte activation, protease expression, and growth factor release, affects over 10% of the global population. In the US alone, more than 30 million adults grapple with OA, as reported by the Centers for Disease Control and Prevention (CDC). The surge in aging and obesity, recognized risk factors, drives its prevalence worldwide. Aging exacerbates the imbalance between catabolic and anabolic activity in joints, leading to cartilage degeneration. The aging populace, especially those over 60 years, is poised to double by 2050 in the US, propelling OA rates. Cartilage repair and regeneration techniques are increasingly pivotal in OA treatment and diabetes, stimulating market growth.
Further, in the realm of healthcare, cardiovascular diseases (CVDs), including hypertension, hyperlipidemia, and coronary heart disease, alongside FDA-approved medications like Eliquis (apixaban) and anticoagulants, demand attention. With advancements in therapy alternatives and management in critical care units, combating heart failure and mortality rates associated with these disorders remains paramount. Hence, these factors will have a positive impact on the growth of the market during the forecast period.
Lucrative opportunities in emerging economies are emerging market trends. The healthcare system in emerging economies is changing rapidly. Emerging economies demonstrate a huge growth potential for medical device manufacturers, owing to the increase in demand for medical devices to serve the growing population, including the geriatric population. These emerging economies have an expanding middle-class population, which demands cost-effective healthcare products and services. Moreover, with rising healthcare expenditures, emerging economies provide significant growth opportunities for medical equipment manufacturers to set up their businesses in these countries.
The improving healthcare infrastructure in emerging markets has attracted the attention of global institutional investors. Moreover, with the low cost of labor and increased spending on healthcare infrastructure, China and India provide huge growth opportunities to medical equipment manufacturers. Although regional companies are making efforts to create innovative products at affordable prices using low-cost local materials, there is still a huge potential for capital investments by global investors in these developing markets. Hence, these factors will have a positive impact on the growth of the market during the forecast period.
The lack of skilled surgeons is a major challenge impeding market expansion. There is a significant shortage of surgeons specialized in surgery and trained in performing procedures. The learning curve of performing a cartilage repair procedure is steep, and experienced orthopedists are necessary for a successful outcome. As the majority of OA is of a posttraumatic or deformity origin, performing a successful cartilage repair procedure requires the knowledge of a broad armamentarium of techniques to address complex pathologies. Thus, the clinical success of a procedure greatly depends on the surgeon's experience and the implantation technique used.
However, currently, the number of qualified orthopedic surgeons with the necessary training and experience to perform cartilage repair surgery is significantly lesser than the number of orthopedic surgeons performing hip and knee replacement surgeries. Moreover, the overall number of specialized centers for surgery is limited, especially in certain regions such as Africa. Even in certain developed countries such as France, the number of skilled orthopedists trained in performing surgery is not adequate. Thus, the lack of skilled surgeons is likely to negatively impact the growth of the global market during the forecast period.
The market report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market research and growth report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.
Customer Landscape
The market research report provides comprehensive data (region wise segment analysis), with forecasts and estimates in "USD Billion" for the period 2024 to 2028, as well as historical data from 2018 to 2022 for the following segments.
Tissue Engineering and Regeneration Market: Tissue Engineering and Regeneration Market Analysis North America, Europe, Asia, Rest of World (ROW) - US, Canada, Germany, UK, China - Size and Forecast
Bovine Based Collagen Market: Bovine Gelatin Market Analysis APAC, North America, Europe, Middle East and Africa, South America - US, China, Germany, Canada, France - Size and Forecast
Cruciate Ligament Repair Procedures Market: Cruciate Ligament Repair Procedures Market by Type and Geography - Forecast and Analysis
The market is gaining traction due to advancements in precision manufacturing techniques and the growing demand for effective solutions in urban areas. The use of materials such as steel, timber, and modular concrete structures in relocatable modular construction is revolutionizing residential applications and industrial modular building methods. This approach, used by companies like Aries Building Systems and VESTA Modular, ensures sustainability and workplace safety while reducing carbon emissions. Despite challenges like transportation issues, assembly issues, and a lack of experts with specialized knowledge, modular construction offers higher quality and efficiency.
Furthermore, the Modular Building Institute highlights significant market growth, particularly in healthcare centers, single-family homes, and modular hotels like International Marriott. With the explosive interest in modular solutions, the industry addresses severe housing shortages in cities like Seattle and Vancouver, ensuring affordable housing and streamlined construction schedules. In regions prone to wildfires, earthquakes, replacing traditional building methods with standardized modules constructed under factory conditions can enhance the resilience and safety of construction site offices.
Market Scope |
|
Report Coverage |
Details |
Page number |
162 |
Base year |
2023 |
Historic period |
2018-2022 |
Forecast period |
2024-2028 |
Growth momentum & CAGR |
Accelerate at a CAGR of 16.79% |
Market Growth 2024-2028 |
USD 1.24 billion |
Market structure |
Fragmented |
YoY growth 2023-2024(%) |
15.62 |
Regional analysis |
North America, Europe, Asia, and Rest of World (ROW) |
Performing market contribution |
North America at 39% |
Key countries |
US, Canada, Germany, UK, and China |
Competitive landscape |
Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks |
Key companies profiled |
3M Co., AlloSource, Arthrex Inc., B.Braun SE, Bioventus LLC, Geistlich Pharma AG, Hy2Care, Johnson and Johnson, Medtronic Plc, Orteq Sports Medicine Ltd., Orthox Ltd., Regentis Biomaterials Ltd., Rosens Diversified Inc., RTI Surgical Inc., Sartorius AG, Smith and Nephew plc, Stryker Corp., TissueTech Inc., Vericel Corp., Xintela AB, Xtant Medical Holdings Inc., and Zimmer Biomet Holdings Inc. |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and market condition analysis for the market forecast period. |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
Download Sample PDF at your Fingertips
We can help! Our analysts can customize this market research report to meet your requirements. Get in touch
1 Executive Summary
2 Market Landscape
3 Market Sizing
4 Historic Market Size
5 Five Forces Analysis
6 Market Segmentation by Product
7 Market Segmentation by End-user
8 Customer Landscape
9 Geographic Landscape
10 Drivers, Challenges, and Trends
11 Vendor Landscape
12 Vendor Analysis
13 Appendix
Get lifetime access to our
Technavio Insights
Quick Report Overview:
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.